Skip to content
VATE

INNOVATE Corp.

INNOVATE Corp. Q3 FY2025 earnings call

November 12, 2025 · fiscal period ended 2025-09

EPS · actual vs est

$-0.71 /

Revenue · actual vs est

$347.1M /
Ask about this call

Summary

Generated 2025-11-12

Management highlights

  • Strategic alternatives: Engaged Jefferies & Company for DBM sales process in accordance with senior note requirements; HC2 Broadcasting exploring strategic alternatives for spectrum debt.
  • Infrastructure: Progress with backlog growth despite margin compression, positive momentum for 2026 due to backlog.
  • Life Sciences: MediBeacon's regulatory approval in China, R2's revenue growth and Glacial Skin's performance.
  • Spectrum: New network launches, though facing advertising challenges, with future potential from new launches
View in transcript ↓

Segment performance

Infrastructure (DBM Global)

  • Revenues: $338.4 million, adjusted EBITDA: $23.5 million. Year-over-year gross margin compression of approximately 510 basis points to 13.6% and adjusted EBITDA margin compression of approximately 200 basis points to 6.9%. Year-to-date revenue stands at $836.4 million. Adjusted backlog increased by approximately $500 million to just over $1.6 billion since the end of 2024.

Life Sciences

  • MediBeacon: Received full regulatory approval in China for Lumitrace injection, with commercial launch in China planned. R2: Q3 2025 revenue $3.1 million (vs $3 million in Q3 2024), year-to-date revenue $9.4 million (+65% Y/Y). Glacial Skin: Patient treatments grew 102%, average monthly utilization per provider increased 24% Y/Y.

Spectrum

  • Q3 2025 revenues $5.6 million, adjusted EBITDA $1 million. New network launches include Lionsgate' MovieSphere Gold Channel, Sports First. Facing challenging advertising environment, but new network launches in Q4 showing signs of strength
View in transcript ↓

Guidance

  • Anticipate EBITDA to be slightly below 2024 levels in 2025 but optimistic for 2026 driven by growing adjusted backlog and improving market conditions.
  • Expect R2 to end the year strongly with its backlog, growing consumable revenue, and new markets in Bolivia, Netherlands, and Belgium.
  • Spectrum new network launches in Q4 showing signs of strength in ad sales
View in transcript ↓

Risks

  • Macro environment challenges affecting project sales and timing shifts.
  • Challenging advertising environment impacting Spectrum's ad sales.
  • Government shutdown temporarily delaying progress on FCC petition for LPTV stations to 5G broadcast
View in transcript ↓

Q&A highlights

Q: There are currently no questions A:

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS$-0.71
Revenue$347.1M

Transcript

November 12, 2025

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.